Disc Medicine (IRON) Share-based Compensation (2020 - 2026)

Disc Medicine (IRON) has reported Share-based Compensation for 7 consecutive years, with $13.9 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Share-based Compensation rose 65.65% year-over-year to $13.9 million; the TTM figure through Jun 2026 stood at $45.5 million (up 93.83% YoY), while the FY2025 annual figure was $101.8 million, up 97.36% from the prior year.
• Share-based Compensation rose to $13.9 million in Q2 2026 per IRON's latest filing, from $11.9 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $13.9 million in Q2 2026 and bottomed at $332000.0 in Q1 2022.
• Historically, Share-based Compensation has averaged $4.7 million across 5 years, with a median of $4.1 million in 2024.
• Annual changes were most pronounced in 2022 — Share-based Compensation plunged 86.65% — and 2024, when it jumped 296.29%.
• Disc Medicine's Share-based Compensation stood at $993000.0 in 2022, then soared by 94.06% to $1.9 million in 2023, then soared by 124.91% to $4.3 million in 2024, then soared by 131.73% to $10.0 million in 2025, then soared by 38.88% to $13.9 million in 2026.
• Business Quant data shows IRON's Share-based Compensation at $13.9 million in Q2 2026, $11.9 million in Q1 2026, and $10.0 million in Q4 2025.